Proliferation of anti-DNA-producing NZB B cells in a non-autoimmune environment
- PMID: 3486918
Proliferation of anti-DNA-producing NZB B cells in a non-autoimmune environment
Abstract
This study demonstrates that purified NZB B cells, but not other NZB spleen cell populations, are capable of transferring anti-DNA antibody production into unirradiated H-2-compatible xid recipients. The number of autoantibody-producing B cells and the concentration of anti-DNA antibody found in the recipients correlated directly with the number of NZB B cells transferred. In addition, the number of anti-DNA-secreting lymphocytes found in the xid hosts increased exponentially with time post cell transfer. Several lines of evidence suggest that this phenomenon reflected the rapid proliferation of donor NZB B cells in the xid environment. Significantly, such proliferation was characteristic of donor cells that produced autoantibodies, but not of splenic B cells as a whole. These results suggest that stimulated NZB B cells can both induce and perpetuate autoantibody production in a normally non-autoimmune environment and in the absence of autoimmune helper cells.
Similar articles
-
Similar in vivo expansion of B cells from normal DBA/2 and autoimmune NZB mice in xid recipients.J Immunol. 1987 Oct 1;139(7):2284-9. J Immunol. 1987. PMID: 3498756
-
Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.J Immunol. 1986 Feb 15;136(4):1247-52. J Immunol. 1986. PMID: 3484766
-
Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.J Immunol. 1993 Mar 15;150(6):2467-77. J Immunol. 1993. PMID: 8450223
-
Comparison of in vitro and in vivo mitogenic and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A, PWM, PHA and Con A in normal and autoimmune mice.J Clin Lab Immunol. 1985 Feb;16(2):93-109. J Clin Lab Immunol. 1985. PMID: 3886911 Review.
-
[The mechanism of autoantibody production in systemic autoimmune diseases].Nihon Rinsho. 1997 Jun;55(6):1468-74. Nihon Rinsho. 1997. PMID: 9200934 Review. Japanese.
Cited by
-
Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.J Clin Invest. 1990 Jan;85(1):238-47. doi: 10.1172/JCI114418. J Clin Invest. 1990. PMID: 1688569 Free PMC article.
-
Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.Infect Immun. 1999 Nov;67(11):5658-63. doi: 10.1128/IAI.67.11.5658-5663.1999. Infect Immun. 1999. PMID: 10531213 Free PMC article.
-
Systemic autoimmune disease arises from polyclonal B cell activation.J Exp Med. 1987 Jun 1;165(6):1755-60. doi: 10.1084/jem.165.6.1755. J Exp Med. 1987. PMID: 3495631 Free PMC article.
-
Active role of T cells in promoting an in vitro autoantibody response to self erythrocytes in NZB mice.Immunology. 1988 Apr;63(4):625-30. Immunology. 1988. PMID: 2966765 Free PMC article.
-
Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.J Clin Invest. 1990 Oct;86(4):1249-54. doi: 10.1172/JCI114831. J Clin Invest. 1990. PMID: 2212009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical